---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-081464"
form_type: "8-K"
ticker: "RPRX"
cik: "0001802768"
company_name: "Royalty Pharma plc"
filed_at: "2023-03-28T23:59:59+00:00"
generated_at: "2026-06-17T13:14:33.222826+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Royalty Pharma adopts Articles amendments to enable share repurchase program

## Summary
- Royalty Pharma Holdings Ltd amended its Articles of Association on March 24, 2023.
- Amendments facilitate the share repurchase program announced by Royalty Pharma plc on March 27, 2023.
- No other changes to governance or fiscal year were made.

## SEC filing metadata
- accession: 0001193125-23-081464
- form_type: 8-K
- ticker: RPRX
- cik: 0001802768
- company_name: Royalty Pharma plc
- filed_at: 2023-03-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802768/000119312523081464/0001193125-23-081464-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802768/000119312523081464/d465824d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-081464
- JSON: https://secwatch.observer/filing/0001193125-23-081464.json
- Plain text: https://secwatch.observer/filing/0001193125-23-081464.txt

## Key facts
- Governance Changes
  Royalty Pharma plc: Amended Articles of Association to facilitate share repurchase program (effective 2023-03-24).
  - Change: bylaw amendment
  - Effective: 2023-03-24
  source text: On March 24, 2023, Royalty Pharma Holdings Ltd adopted amendments to its Articles of Association (the “RP Holdings Articles of Association”) to facilitate the share repurchase program that was announced by Royalty Pharma plc on March 27, 2023. The RP Holdings Articles of Association are filed herewith as Exhibit 3.2.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1802768/000119312523081464/0001193125-23-081464-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.